Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility
Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.
With you from
pre-clinical to market.
Integrated CDMO services to accelerate and de-risk your drug product journey.
Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.
What a year 2023 has been. A year of remarkable growth and achievements, award-winning, and
Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO) specialising in the development
A CDMO like no other. Simply, delivered better.
As a leading Contract, Development and Manufacturing Organisation (CDMO) our defining traits lie in our adaptability and nimbleness, enabling rapid product introduction.
Through a science-led approach we align to your drug development needs from pre-clinical to late phase commercial manufacture.
With more than 25 years of experience, count on us to navigate the complexities of your project with precision, expertise and our unique approach to project delivery.
Science-led delivery. Expertise you can trust.
Our team support you at each stage from pre-clinical to market.
We are dedicated to changing the lives of patients.
Passionate about science, we strive to build strong customer relationships and exceed their expectations.
We develop and manufacture high-quality drug products and share in our customers’ dedication to change the lives of patients.
We are flexible and nimble.
We can adapt to your project needs.
Our extensive expertise encompasses the development, scale-up, manufacturing, and rigorous testing of oral, pulmonary, and nasal drug products.
Our flexibility ensures that we can problem-solve, meet your timescales, and deliver solutions that meet patient targets.
Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.
What a year 2023 has been. A year of remarkable growth and achievements, award-winning, and new standards in gmp manufacturing
Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO) specialising in the development and manufacture of innovative drug
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK NG7 2TN,
Phone: +44 (0) 115 855 7050
Email: contact@upperton.com
Copyright © 2024 Upperton Limited. All rights reserved.